https://yestino.com/entities/revolution-medicines-c101a7Every event involving Revolution Medicinesenhttps://yestino.com/events/fda-approves-revolution-medicines-first-targeted-drug-for-ad-35e5fahttps://yestino.com/events/fda-approves-revolution-medicines-first-targeted-drug-for-ad-35e5faWed, 26 Aug 2026 18:20:38 GMTThe drug, Rasonque, nearly doubled median overall survival compared with standard chemotherapy in a 500-patient trial Sources: Quartz